Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Combining stem cell media with laser or microneedling can effectively regrow hair in alopecia areata.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

PRP injections help relieve hip pain in most cases.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Platelet-rich plasma therapy may help treat folliculitis decalvans but benefits might not last without ongoing treatment.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Excimer laser therapy can help regrow hair in alopecia areata but is less effective for severe cases and has mixed results for cicatricial alopecia.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Upadacitinib improved multiple immune-related conditions in one patient.

Tofacitinib is effective and safe for treating severe alopecia areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

A child was initially wrongly diagnosed with a fungal scalp infection but actually had a non-scarring hair loss condition called Temporal Triangular Alopecia.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Tofacitinib helped regrow hair in most patients with severe hair loss.